Essays about: "pharmaceutical patents"
Showing result 11 - 15 of 40 essays containing the words pharmaceutical patents.
-
11. Reverse payment settlements in the context of Article 102 TFEU: Abusive or not? By object or not?
University essay from Lunds universitet/Juridiska institutionenAbstract : Pharmaceutical reverse payment settlements lie at the intersection of competition law and intellectual property law. In the recent years, these settlement agreements have increasingly attracted the attention of competition law authorities in the European Union. READ MORE
-
12. Protection of Traditional Medical Knowledge in the Patent System: Is There Room?
University essay from Uppsala universitet/Juridiska institutionenAbstract : Traditional knowledge (TK) is a vital component of the lives and wellbeing of many traditional communities or groups worldwide. The value of TK extends to numerous aspects of life including the health sector. In Africa, up to 80% of the population use traditional medicine or employ medicinal use of indigenous plants. READ MORE
-
13. End of a blockbuster? – Preventing evergreening of pharmaceutical patents under EU competition law
University essay from Lunds universitet/Juridiska institutionenAbstract : The pharmaceutical industry is dependent on the granting of patents. Patents make it possible for pharmaceutical companies to invest in the necessary R&D to bring new drugs to the market. This benefits consumers and the health care sector at large. READ MORE
-
14. Who can compete? Analysing the concept of potential competition in reverse patent settlements
University essay from Lunds universitet/Juridiska institutionenAbstract : After the General Court’s (GC) decision in case T-472/13 H. Lundbeck A/S and Lundbeck Ltd v Commission it seems the concept of potential competition in the context of so-called ‘pay-for-delay’ agreements, or reverse patent settlements, might have been altered; that the bar in order for an undertaking to qualify as a potential competitor might have been lowered. READ MORE
-
15. A Skinny Label - The intersection of EU competition law and patent law, and the abuse of dominance by the enforcement of second medical use patents
University essay from Lunds universitet/Juridiska institutionenAbstract : EU competition law is the safeguard of the functioning of the internal market, and not many fields of law other than patent law can delimit the scope of competition law. A patent’s value is based upon an exclusive right to the invention and product as protected by the patent. READ MORE